Saudi Arabia Pulmonary Embolism Therapeutics Market Size & Outlook, 2026-2034

Saudi Arabia Pulmonary Embolism Therapeutics Market Insights

Reed Intelligence analysis indicates that the Saudi Arabia Pulmonary Embolism Therapeutics Market size, valued at USD 60.55 Million in 2025, is expected to expand to USD 122.23 Million by 2034.
The Saudi Arabia market is forecasted to expand at a CAGR of 8.1% spanning 2026–2034.
Anticoagulants held the leading position among Drug Class segments in 2025, based on market size.
Thrombolytics is projected to post the fastest growth rate, sustaining its position as the most attractive Drug Class segment during the forecast horizon.

Other Key Findings

In 2025, Saudi Arabia accounted for 1.59% of the global Pulmonary Embolism Therapeutics Market size.
By 2034, United States is expected to lead the global Pulmonary Embolism Therapeutics Market in terms of market size.
Within Middle East and Africa, United Arab Emirates is projected to dominate the regional Pulmonary Embolism Therapeutics Market size by 2034.
Egypt is identified as the fastest-growing market in Middle East and Africa, anticipated to reach USD 90.63 Million by 2034.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 60.55 Million
Market Size In 2034	USD 122.23 Million
Largest segment	Anticoagulants
Units	Revenue in USD Million
CAGR	8.1% (2026-2034)
Segmnetation Covered
Drug Class	Anticoagulants Thrombolytics Others
Route of Administration	Oral Injectable
End-Use	Hospitals Ambulatory Surgical Centers Specialty Clinics
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Saudi Arabia Pulmonary Embolism Therapeutics Market Drug Class 2026-2034 (USD Million)

Drug Class	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Anticoagulants	XX.x	XX.x	XX.x	27.28	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Thrombolytics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Others	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Saudi Arabia Pulmonary Embolism Therapeutics Market Route of Administration 2026-2034 (USD Million)

Route of Administration	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Oral	XX.x	XX.x	XX.x	33.63	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Injectable	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Saudi Arabia Pulmonary Embolism Therapeutics Market End-Use 2026-2034 (USD Million)

End-Use	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Hospitals	XX.x	XX.x	XX.x	32.68	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Ambulatory Surgical Centers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Specialty Clinics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.